Get started
Author

Kandai Ishikura

ORCID: 0000-0002-5669-9311
Observed ORCID: 0000-0002-5669-9311
OpenAlex ID: A5078194219
Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery
2020 · Ryoma Yokoyama, Toru Taharabaru, et al. · Journal of Controlled Release · 37
Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann–Pick Type C Disease Model Mice
2022 · Takumi Nishida, Ryoma Yokoyama, et al. · ACS Applied Bio Materials · 10
A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice
2025 · Yuto Kubohira, Nanami Okano, et al. · Carbohydrate Polymers · 2
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
A preclinical study evaluating how degrees of substitution beyond the pharmacopeial range of 2-hydroxypropyl-β-cyclodextrin affect therapeutic efficacy and auditory function after intracerebroventricular administration for Niemann–Pick disease type C
2026 · Mayuko Tanaka, Hazuki Nakagawa, et al. · SSRN Electronic Journal
PDF
2-Hydroxypropyl-Β-Cyclodextrin with a High Degree of Substitution Has Higher Ability to Solubilize Cholesterol But a Weaker Therapeutic Effect on Niemann–Pick Disease Type C
2025 · Akira Ishii, Mayuko Tanaka, et al. · SSRN Electronic Journal
Synthesis of branched cyclodextrins using activated carbon as a catalyst
2021 · Kandai Ishikura, Kazunori Yanagihara, et al. · Journal of Inclusion Phenomena and Macrocyclic Chemistry
Works count: 13
Citation count: 49
H-index: 2
I10-index: 2
Year
Topic
Type